Temporal indication of cannabis use by means of THC glucuronide determination. - Wikidata - wikimedia - TriplyDB

Temporal indication of cannabis use by means of THC glucuronide determination.

Temporal indication of cannabis use by means of THC glucuronide determination.

http://www.wikidata.org/entity/Q34618371

about

In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.Recent advances in LC-MS/MS analysis of Δ(9)-tetrahydrocannabinol and its metabolites in biological matrices.Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices.Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity.Comparison of Different Time of Flight-Mass Spectrometry Modes for Small Molecule Quantitative Analysis.Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry.

P2860

Q34655618-4E4B6937-54CB-4AE0-BBBE-B2092F0EF5C3 Q35173356-7CF5607A-7120-4219-9305-E1894FF9CC4A Q36288355-A9135CE4-54CA-48A3-94FD-3AC95F4351AC Q36471630-5B3B2A08-D2E8-49AE-BB05-F202ACAE992C Q37029480-47DB3076-7B2D-481A-9FC6-82C786789C29 Q37351687-92517F5D-F9D2-493F-A0F8-72F2F570844B Q38127386-CD500F58-358B-4729-8779-0E155F80B239 Q38158190-0C73822D-ADFF-4B70-BE2D-833653D17E37 Q38161854-1C1B5776-B058-4539-9888-71DC6252F5A6 Q38717316-5BEA4429-F409-413C-9EC1-1E4FA57B9E4A Q40663453-018E5297-2D24-482B-AF39-75A0C9B2F6F0 Q54349679-A9558432-45F8-4F27-A09F-526F802C0685

P2860

Temporal indication of cannabis use by means of THC glucuronide determination.

http://www.wikidata.org/entity/Q34618371

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Temporal indication of cannabis use by means of THC glucuronide determination.

@ast

Temporal indication of cannabis use by means of THC glucuronide determination.

@en

Temporal indication of cannabis use by means of THC glucuronide determination.

@nl

type

label

Temporal indication of cannabis use by means of THC glucuronide determination.

@ast

Temporal indication of cannabis use by means of THC glucuronide determination.

@en

Temporal indication of cannabis use by means of THC glucuronide determination.

@nl

prefLabel

Temporal indication of cannabis use by means of THC glucuronide determination.

@ast

Temporal indication of cannabis use by means of THC glucuronide determination.

@en

Temporal indication of cannabis use by means of THC glucuronide determination.

@nl

P1433

Q34618371-8E2C5709-D848-49AD-BA9B-8A62270A9ED8

P1476

Q34618371-C9D3B114-35A1-423A-A760-227BA0BE691C

P2093

Q34618371-06D11D1B-792A-4838-B097-BB1A07D88507

Q34618371-138F916A-4281-4BDE-86EB-B915B83ECE3D

Q34618371-2011CCD6-64A3-4499-8ED7-826C13229875

Q34618371-820FFF1B-F565-44CA-A197-5848C210E369

Q34618371-B95E34AD-1135-4A55-9665-DEB47B24A3A9

Q34618371-C5CA2CFA-77AA-4B84-8C5D-E9D26DD1B8DA

P2860

Q34618371-0CD9A8D9-9B53-45DA-9399-6FD9DB134489

Q34618371-261FE941-5B9D-4145-BB91-44A7D0F60E65

Q34618371-34BE81B0-8C5D-4CD1-9513-F5C72F07F46B

Q34618371-52631404-9F28-4DFC-A377-C790F0C91C33

Q34618371-566E1B46-A06F-4E8F-93CD-327EA64AE597

Q34618371-5DDB9886-7432-4C18-A70D-69053369B94D

Q34618371-6222EEC9-68D0-4C39-89CB-6808B2ABBA5B

Q34618371-7D15D3A2-F572-4E41-9D7A-72C0FC996094

Q34618371-AB75D7B6-F41E-4DB1-AAAB-A7CAB9638F86

Q34618371-F2F8B134-D887-4204-8444-68716F7B9F60

P304

Q34618371-11C7D3AA-F436-4929-A755-C281D6CC9A2D

P31

Q34618371-82DE4F89-A715-47AA-B4AE-D0C5F36470C6

P356

Q34618371-896A8A8E-518F-4B23-8C65-6CAB42E70CE7

P433

Q34618371-96B1C03C-8295-462A-9DA9-98F33AEB034B

P478

Q34618371-6FFC85C8-10F1-49A3-B41D-288618287C33

P50

Q34618371-AD71F4B3-DCAC-4426-B2B4-7A975F6EADFD

Q34618371-D0C78F9E-C310-463D-9F1E-3AE50786078B

P577

Q34618371-D097B49F-5573-4873-91B9-DD49BD3B987A

P5875

Q34618371-8A17C640-9499-4540-AB92-2302D9950654

P698

Q34618371-5737C4FF-EBDD-468B-BCD2-35EDABB9E432

P921

Q34618371-0AE30329-14FB-4CA1-9C21-32503DAD45CC

Q34618371-C5247B29-8242-488D-A9DE-EE942845F66B

P356

P1433

Drug Testing and Analysis

P1476

Temporal indication of cannabis use by means of THC glucuronide determination.

@en

P2093

Hans Geyer

http://www.w3.org/2001/XMLSchema#string

Matthias Kamber

http://www.w3.org/2001/XMLSchema#string

Nadine Haenelt

http://www.w3.org/2001/XMLSchema#string

Rudolf Brenneisen

http://www.w3.org/2001/XMLSchema#string

Sven Guddat

http://www.w3.org/2001/XMLSchema#string

Ute Mareck

http://www.w3.org/2001/XMLSchema#string

P2860

Detection times of marijuana metabolites in urine by immunoassay and GC-MS.

Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.

Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.

Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.

Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.

Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.

An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.

Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.

Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine.

P304

505-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DTA.106

http://www.w3.org/2001/XMLSchema#string

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Wilhelm Schänzer

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42769343

http://www.w3.org/2001/XMLSchema#string

P698

20355165

http://www.w3.org/2001/XMLSchema#string

P921

tetrahydrocannabinol